Handelsbanken Fonder AB grew its holdings in Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 11.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 44,500 shares of the company’s stock after buying an additional 4,500 shares during the quarter. Handelsbanken Fonder AB’s holdings in Astera Labs were worth $21,494,000 at the end of the most recent quarter.
Several other hedge funds have also modified their holdings of the business. Eurizon Capital SGR S.p.A. purchased a new stake in shares of Astera Labs during the 4th quarter worth approximately $18,708,000. Swedbank AB increased its stake in Astera Labs by 76.8% in the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock valued at $12,999,000 after purchasing an additional 33,940 shares in the last quarter. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new position in Astera Labs during the fourth quarter worth $499,000. Revere Asset Management Inc acquired a new position in Astera Labs during the fourth quarter worth $589,000. Finally, Mitsubishi UFJ Trust & Banking Corp purchased a new stake in Astera Labs during the fourth quarter worth $10,299,000. 60.47% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of research analysts have recently weighed in on ALAB shares. Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. UBS Group reissued a “neutral” rating and issued a $425.00 price objective on shares of Astera Labs in a research note on Wednesday, August 5th. Morgan Stanley raised their target price on shares of Astera Labs to $335.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Roth Capital restated a “buy” rating and set a $450.00 target price on shares of Astera Labs in a research report on Wednesday, August 5th. Finally, Royal Bank Of Canada upped their price target on shares of Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a report on Wednesday, August 5th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $325.25.
Key Headlines Impacting Astera Labs
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: AI infrastructure opportunity: Astera’s Scorpio high-radix fabric switch could become its largest revenue source, increasing average selling prices and enabling cross-selling across its connectivity portfolio. An analyst rates ALAB a Buy with a $370 price target, citing the company’s interoperability, software controls and positioning across different accelerator platforms. Astera Labs: The AI Fabric Inflection Is Arriving Faster Than Expected
- Positive Sentiment: Connectivity demand remains strong: Astera’s record growth, PCIe 6 capabilities and expanding product lineup may help it gain share against Marvell and Credo, supporting continued revenue and earnings momentum. ALAB Benefits From PCIe Demand: Can It Stay Ahead of Its Competitors?
- Positive Sentiment: Profit forecasts were sharply raised: Northland Securities lifted its FY2026 EPS estimate to $2.75 from $1.82 and its FY2027 estimate to $5.43 from $2.26. Quarterly estimates were also increased substantially, indicating expectations for faster operating growth.
- Positive Sentiment: AMD ecosystem tailwind: AMD’s Helios rack-scale AI systems are expected to ramp, potentially benefiting Astera Labs as an infrastructure and connectivity supplier alongside other ecosystem partners. AMD’s Helios Launch Could Create Winners Beyond AMD Stock
- Neutral Sentiment: Recent coverage compares ALAB’s performance with the broader technology sector and ASE Technology, but provides no specific new catalyst or downgrade.
- Negative Sentiment: Northland maintained a “Market Perform” rating despite raising estimates. ALAB also trades at a very demanding valuation, with a price-to-earnings ratio above 200 and a share price below its 50-day average, leaving the stock sensitive to any slowdown in AI spending or execution.
Insiders Place Their Bets
In related news, CEO Jitendra Mohan sold 111,214 shares of the company’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $216.89, for a total transaction of $24,121,204.46. Following the transaction, the chief executive officer owned 3,817,969 shares of the company’s stock, valued at approximately $828,079,296.41. This represents a 2.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the firm’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the sale, the director owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 1,256,894 shares of company stock valued at $362,763,135. 10.40% of the stock is currently owned by insiders.
Astera Labs Trading Up 2.2%
Astera Labs stock opened at $318.80 on Thursday. The stock has a 50-day moving average price of $358.62 and a 200 day moving average price of $238.55. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The stock has a market cap of $55.31 billion, a PE ratio of 157.82 and a beta of 3.84.
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same period in the prior year, the firm earned $0.44 EPS. The firm’s quarterly revenue was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current year.
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
See Also
- Five stocks we like better than Astera Labs
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
